Knight Therapeutics Inc - Jul 11, 2023 Form 3 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Role
10%+ Owner
Signature
KNIGHT THERAPEUTICS INTERNATIONAL S.A. By: /s/ Arvind Utchanah Name: Arvind Utchanah Title: President of the Board of Directors
Stock symbol
SXTP
Transactions as of
Jul 11, 2023
Transactions value $
$0
Form type
3
Date filed
12/18/2023, 09:23 AM
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SXTP Common Stock, $0.0001 par value per share ("Common Shares") 1.11M Jul 11, 2023 By Knight Therapeutics International SA F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In addition to Knight Therapeutics Inc., a Canadian corporation ("Knight Parent"), this Form 3 is being jointly filed by Knight Therapeutics International S.A., an Uruguayan corporation ("Knight Subsidiary" and collectively with Knight Parent, the "Reporting Persons").
F2 Knight Subsidiary directly beneficially owns 1,108,337 Common Shares.
F3 Knight Parent is the sole owner of Knight Subsidiary and, as a result, may be deemed the beneficial owner for purposes of Securities Exchange Act of 1934 (the "Act") of any securities of 60 Degrees Pharmaceuticals, Inc. (the "Issuer") beneficially owned by Knight Subsidiary. Knight Parent disclaims beneficial ownership over all of the Common Shares beneficially owned by Knight Subsidiary, other than for the purpose of determining obligations under the Act, and the filing of this Form 3 shall not be deemed an admission that Knight Parent is the beneficial owner of such securities for any other purpose.

Remarks:

Exhibit 99.1 (Joint Filer Information) incorporated herein by reference.